HRTX · Heron Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Rubric Capital Management LP 10% Owner | ▼ Sell | Other | 30,046,828 Shares held | 10/15/2025 | View profile |
| Collard Craig A Chief Executive Officer | ▲ Buy | Option Exercise | 856,492 Shares held | 7/31/2026 | View profile |
| Duarte Ira EVP, Chief Financial Officer | ▼ Sell | Tax Withholding | 281,899 Shares held | 7/31/2026 | View profile |
| Forbes William P Director | ▼ Sell | Tax Withholding | 241,173 Shares held | 7/31/2026 | View profile |
| Quart Barry D Chief Executive Officer | ▼ Sell | Tax Withholding | 177,989 Shares held | 1/13/2023 | View profile |
| Hensley Mark Earl Chief Operating Officer | ▼ Sell | Tax Withholding | 170,901 Shares held | 8/6/2026 | View profile |
| Morgan Adam Director | ▲ Buy | Grant | 123,737 Shares held | 1/30/2026 | View profile |
| Rodriguez Susan Chief Commercial Officer | ▲ Buy | Grant | 87,180 Shares held | 1/30/2025 | View profile |
| Peraza Lisa VP, Chief Accounting Officer | ▼ Sell | Tax Withholding | 55,907 Shares held | 1/13/2024 | View profile |
| Craig A. Johnson Director | ▲ Buy | Grant | 53,960 Shares held | 1/30/2026 | View profile |
| Michael Kaseta Chief Financial Officer | ▲ Buy | Grant | 53,960 Shares held | 1/30/2026 | View profile |
| Christian Waage Director | ▲ Buy | Grant | 53,960 Shares held | 1/30/2026 | View profile |
| Cusack Thomas | ▲ Buy | Grant | 53,960 Shares held | 1/30/2026 | View profile |
| Dissanaike Sharmila Director | ▲ Buy | Grant | 53,960 Shares held | 1/30/2026 | View profile |
| DAVIS STEPHEN CEO | ▲ Buy | Grant | 52,032 Shares held | 12/16/2022 | View profile |
| POYHONEN JOHN President & CCO | ▼ Sell | Tax Withholding | 46,648 Shares held | 4/13/2023 | View profile |
| Szekeres David Leslie EVP, Chief Operating Officer | ▼ Sell | Tax Withholding | 33,754 Shares held | 7/13/2023 | View profile |
| Kimberly Manhard Director | ▼ Sell | Tax Withholding | 28,330 Shares held | 4/13/2023 | View profile |
Transaction History
| Hensley Mark Earl | ▲ Buy | Option Exercise | 31,250 | — | 8/6/2026 |
| Hensley Mark Earl | ▼ Sell | Tax Withholding | 8,888 | $4K | 8/6/2026 |
| Hensley Mark Earl | ▲ Buy | Option Exercise | 11,769 | — | 7/31/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 11,694 | — | 7/31/2026 |
| Forbes William P | ▼ Sell | Tax Withholding | 3,326 | $2K | 7/31/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 11,694 | — | 7/31/2026 |
| Duarte Ira | ▼ Sell | Tax Withholding | 3,326 | $2K | 7/31/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 34,789 | — | 7/31/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 50,021 | — | 7/30/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 11,769 | — | 7/30/2026 |
| Forbes William P | ▼ Sell | Tax Withholding | 3,348 | $2K | 7/30/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 13,535 | — | 7/30/2026 |
| Duarte Ira | ▼ Sell | Tax Withholding | 3,850 | $2K | 7/30/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 7/19/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 3,874 | — | 7/19/2026 |
| Forbes William P | ▼ Sell | Tax Withholding | 1,101 | $517 | 7/19/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,874 | — | 7/19/2026 |
| Duarte Ira | ▼ Sell | Tax Withholding | 1,101 | $517 | 7/19/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 12,500 | — | 6/16/2026 |
| Duarte Ira | ▼ Sell | Tax Withholding | 3,555 | $1K | 6/16/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 12,500 | — | 6/6/2026 |
| Hensley Mark Earl | ▲ Buy | Option Exercise | 125,000 | — | 5/6/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 11,694 | — | 4/30/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 13,535 | — | 4/30/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 34,789 | — | 4/30/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 50,021 | — | 4/30/2026 |
| Hensley Mark Earl | ▲ Buy | Option Exercise | 11,770 | — | 4/30/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 11,694 | — | 4/30/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 11,770 | — | 4/30/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 4/19/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,874 | — | 4/19/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 3,874 | — | 4/19/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 62,500 | — | 4/3/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 11,695 | — | 1/31/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 34,789 | — | 1/31/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 11,695 | — | 1/31/2026 |
| Craig A. Johnson | ▲ Buy | Grant | 53,960 | $0 | 1/30/2026 |
| Christian Waage | ▲ Buy | Grant | 53,960 | $0 | 1/30/2026 |
| Cusack Thomas | ▲ Buy | Grant | 53,960 | $0 | 1/30/2026 |
| Dissanaike Sharmila | ▲ Buy | Grant | 53,960 | $0 | 1/30/2026 |
| Michael Kaseta | ▲ Buy | Grant | 53,960 | $0 | 1/30/2026 |
| Morgan Adam | ▲ Buy | Grant | 53,960 | $0 | 1/30/2026 |
| Forbes William P | ▲ Buy | Option Exercise | 3,875 | — | 1/19/2026 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,875 | — | 1/19/2026 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 1/19/2026 |
| Cusack Thomas | ▲ Buy | Grant | 37,879 | — | 11/8/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 11,694 | — | 10/31/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 34,789 | — | 10/31/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 11,694 | — | 10/31/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 3,874 | — | 10/19/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,874 | — | 10/19/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 10/19/2025 |
| Rubric Capital Management LP | ▼ Sell | Other | 946,100 | — | 10/15/2025 |
| Rubric Capital Management LP | ▲ Buy | Open Market | 2,387,225 | $3.6M | 8/8/2025 |
| Morgan Adam | ▲ Buy | Open Market | 1,766,546 | $2.6M | 8/8/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 11,695 | — | 7/31/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 11,695 | — | 7/31/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 34,789 | — | 7/31/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 3,874 | — | 7/19/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,874 | — | 7/19/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 7/19/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 12,500 | — | 6/16/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 12,500 | — | 6/6/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 11,694 | — | 4/30/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 34,789 | — | 4/30/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 11,694 | — | 4/30/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,875 | — | 4/19/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,796 | — | 4/19/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 3,875 | — | 4/19/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 62,500 | — | 4/3/2025 |
| Dissanaike Sharmila | ▲ Buy | Grant | 17,950 | $0 | 1/30/2025 |
| Rodriguez Susan | ▲ Buy | Grant | 17,950 | $0 | 1/30/2025 |
| Michael Kaseta | ▲ Buy | Grant | 17,950 | $0 | 1/30/2025 |
| Craig A. Johnson | ▲ Buy | Grant | 17,950 | $0 | 1/30/2025 |
| Christian Waage | ▲ Buy | Grant | 17,950 | $0 | 1/30/2025 |
| Morgan Adam | ▲ Buy | Grant | 17,950 | $0 | 1/30/2025 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,874 | — | 1/19/2025 |
| Forbes William P | ▲ Buy | Option Exercise | 3,874 | — | 1/19/2025 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 1/19/2025 |
| Michael Kaseta | ▲ Buy | Grant | 37,879 | — | 11/4/2024 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,874 | — | 10/19/2024 |
| Forbes William P | ▲ Buy | Option Exercise | 3,874 | — | 10/19/2024 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 10/19/2024 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 7/19/2024 |
| Forbes William P | ▲ Buy | Option Exercise | 3,875 | — | 7/19/2024 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,875 | — | 7/19/2024 |
| Duarte Ira | ▲ Buy | Option Exercise | 12,500 | — | 6/16/2024 |
| Forbes William P | ▲ Buy | Option Exercise | 12,500 | — | 6/6/2024 |
| Duarte Ira | ▲ Buy | Option Exercise | 3,874 | — | 4/19/2024 |
| Duarte Ira | ▼ Sell | Tax Withholding | 1,122 | $3K | 4/19/2024 |
| Forbes William P | ▲ Buy | Option Exercise | 3,874 | — | 4/19/2024 |
| Collard Craig A | ▲ Buy | Option Exercise | 13,797 | — | 4/19/2024 |
| Collard Craig A | ▲ Buy | Option Exercise | 62,500 | — | 4/3/2024 |
| Morgan Adam | ▲ Buy | Grant | 13,948 | $0 | 1/19/2024 |
| Dissanaike Sharmila | ▲ Buy | Grant | 13,948 | $0 | 1/19/2024 |
| Craig A. Johnson | ▲ Buy | Grant | 13,948 | $0 | 1/19/2024 |
| Christian Waage | ▲ Buy | Grant | 13,948 | $0 | 1/19/2024 |
| Rodriguez Susan | ▲ Buy | Grant | 13,948 | $0 | 1/19/2024 |
| Peraza Lisa | ▲ Buy | Option Exercise | 552 | — | 1/13/2024 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,289 | — | 1/13/2024 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 756 | $2K | 1/13/2024 |
| Forbes William P | ▲ Buy | Open Market | 25,000 | $27K | 11/17/2023 |
| Forbes William P | ▲ Buy | Open Market | 50,000 | $47K | 11/16/2023 |
| Collard Craig A | ▲ Buy | Open Market | 150,000 | $138K | 11/16/2023 |
| Duarte Ira | ▲ Buy | Open Market | 85,000 | $76K | 11/16/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 552 | — | 10/13/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,932 | — | 10/13/2023 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 860 | $619 | 10/13/2023 |
| Collard Craig A | ▼ Sell | Tax Withholding | 692 | $1K | 8/22/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 42,631 | — | 7/25/2023 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 14,743 | $22K | 7/25/2023 |
| Morgan Adam | ▲ Buy | Open Market | 2,486,744 | $3.4M | 7/21/2023 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 1,250 | — | 7/13/2023 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 4,564 | — | 7/13/2023 |
| Szekeres David Leslie | ▼ Sell | Tax Withholding | 2,012 | $3K | 7/13/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 552 | — | 7/13/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,933 | — | 7/13/2023 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 860 | $1K | 7/13/2023 |
| Collard Craig A | ▼ Sell | Tax Withholding | 691 | $1K | 5/22/2023 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 1,250 | — | 4/13/2023 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 4,564 | — | 4/13/2023 |
| Szekeres David Leslie | ▼ Sell | Tax Withholding | 2,012 | $6K | 4/13/2023 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 1,250 | — | 4/13/2023 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 4,564 | — | 4/13/2023 |
| POYHONEN JOHN | ▼ Sell | Tax Withholding | 2,012 | $6K | 4/13/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 552 | — | 4/13/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,932 | — | 4/13/2023 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 860 | $2K | 4/13/2023 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 1,250 | — | 4/13/2023 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 4,564 | — | 4/13/2023 |
| Kimberly Manhard | ▼ Sell | Tax Withholding | 1,417 | $4K | 4/13/2023 |
| Morgan Adam | ▲ Buy | Grant | 37,879 | $0 | 2/22/2023 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 4,564 | — | 1/13/2023 |
| Szekeres David Leslie | ▼ Sell | Tax Withholding | 2,012 | $6K | 1/13/2023 |
| Quart Barry D | ▲ Buy | Option Exercise | 3,645 | — | 1/13/2023 |
| Quart Barry D | ▲ Buy | Option Exercise | 16,122 | — | 1/13/2023 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 1,250 | — | 1/13/2023 |
| Quart Barry D | ▼ Sell | Tax Withholding | 5,219 | $17K | 1/13/2023 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 1,250 | — | 1/13/2023 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 4,564 | — | 1/13/2023 |
| POYHONEN JOHN | ▼ Sell | Tax Withholding | 2,012 | $6K | 1/13/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 552 | — | 1/13/2023 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,933 | — | 1/13/2023 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 1,013 | $3K | 1/13/2023 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 1,250 | — | 1/13/2023 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 4,564 | — | 1/13/2023 |
| Kimberly Manhard | ▼ Sell | Tax Withholding | 2,012 | $6K | 1/13/2023 |
| Christian Waage | ▲ Buy | Grant | 38,580 | $0 | 12/16/2022 |
| Rodriguez Susan | ▲ Buy | Grant | 38,580 | $0 | 12/16/2022 |
| Craig A. Johnson | ▲ Buy | Grant | 38,580 | $0 | 12/16/2022 |
| Dissanaike Sharmila | ▲ Buy | Grant | 38,580 | $0 | 12/16/2022 |
| DAVIS STEPHEN | ▲ Buy | Grant | 38,580 | $0 | 12/16/2022 |
| Quart Barry D | ▼ Sell | Other | 1,655 | $5K | 10/31/2022 |
| Szekeres David Leslie | ▼ Sell | Other | 1,654 | $5K | 10/31/2022 |
| Kimberly Manhard | ▼ Sell | Other | 1,655 | $5K | 10/31/2022 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 1,250 | — | 10/13/2022 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 4,564 | — | 10/13/2022 |
| Szekeres David Leslie | ▼ Sell | Tax Withholding | 2,012 | $8K | 10/13/2022 |
| Quart Barry D | ▲ Buy | Option Exercise | 3,646 | — | 10/13/2022 |
| Quart Barry D | ▲ Buy | Option Exercise | 16,122 | — | 10/13/2022 |
| Quart Barry D | ▼ Sell | Tax Withholding | 5,219 | $20K | 10/13/2022 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 1,250 | — | 10/13/2022 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 4,564 | — | 10/13/2022 |
| POYHONEN JOHN | ▼ Sell | Tax Withholding | 2,012 | $8K | 10/13/2022 |
| Peraza Lisa | ▲ Buy | Option Exercise | 553 | — | 10/13/2022 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,932 | — | 10/13/2022 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 861 | $3K | 10/13/2022 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 1,250 | — | 10/13/2022 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 4,564 | — | 10/13/2022 |
| Kimberly Manhard | ▼ Sell | Tax Withholding | 2,012 | $8K | 10/13/2022 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 4,564 | — | 7/13/2022 |
| POYHONEN JOHN | ▼ Sell | Tax Withholding | 2,012 | $6K | 7/13/2022 |
| Peraza Lisa | ▲ Buy | Option Exercise | 552 | — | 7/13/2022 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,933 | — | 7/13/2022 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 860 | $3K | 7/13/2022 |
| Kimberly Manhard | ▼ Sell | Tax Withholding | 2,012 | $6K | 7/13/2022 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 4,564 | — | 7/13/2022 |
| Kimberly Manhard | ▲ Buy | Option Exercise | 1,250 | — | 7/13/2022 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 4,564 | — | 7/13/2022 |
| Szekeres David Leslie | ▼ Sell | Tax Withholding | 2,012 | $6K | 7/13/2022 |
| Quart Barry D | ▲ Buy | Option Exercise | 3,646 | — | 7/13/2022 |
| Quart Barry D | ▲ Buy | Option Exercise | 16,122 | — | 7/13/2022 |
| Quart Barry D | ▼ Sell | Tax Withholding | 5,219 | $16K | 7/13/2022 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 1,250 | — | 7/13/2022 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 1,250 | — | 7/13/2022 |
| Kimberly Manhard | ▼ Sell | Open Market | 1,504 | $7K | 5/3/2022 |
| Kimberly Manhard | ▼ Sell | Other | 1,504 | $6K | 4/29/2022 |
| Quart Barry D | ▼ Sell | Other | 1,504 | $6K | 4/29/2022 |
| Szekeres David Leslie | ▼ Sell | Other | 1,505 | $6K | 4/29/2022 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 1,250 | — | 4/13/2022 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 1,250 | — | 4/13/2022 |
| POYHONEN JOHN | ▲ Buy | Option Exercise | 4,564 | — | 4/13/2022 |
| Peraza Lisa | ▲ Buy | Option Exercise | 552 | — | 4/13/2022 |
| Peraza Lisa | ▲ Buy | Option Exercise | 1,932 | — | 4/13/2022 |
| Peraza Lisa | ▼ Sell | Tax Withholding | 860 | $5K | 4/13/2022 |
| Szekeres David Leslie | ▲ Buy | Option Exercise | 4,564 | — | 4/13/2022 |
| Szekeres David Leslie | ▼ Sell | Tax Withholding | 2,012 | $12K | 4/13/2022 |
| Quart Barry D | ▲ Buy | Option Exercise | 3,646 | — | 4/13/2022 |
| Quart Barry D | ▲ Buy | Option Exercise | 16,122 | — | 4/13/2022 |
| Quart Barry D | ▼ Sell | Tax Withholding | 5,219 | $32K | 4/13/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Heron Therapeutics Signs U.S. License Deal
Heron Therapeutics has entered a multi-product development and license agreement granting it exclusive rights to market products in the U.S. The company is obligated to pay milestone and royalty payments under this new arrangement. This development provides a potential pathway for future revenue, though the stock currently trades well below the average analyst target price.
Heron Therapeutics Signs U.S. License Deal. Heron Therapeutics has entered a multi-product development and license agreement granting it exclusive rights to market products in the U.S. The company is obligated to pay milestone and royalty payments under this new arrangement. This development provides a potential pathway for future revenue, though the stock currently trades well below the average analyst target price.